Cargando…

Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review

Detalles Bibliográficos
Autores principales:	Alzghari, Saeed K., Acuña, Valerie S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194791/ https://www.ncbi.nlm.nih.gov/pubmed/32353761 http://dx.doi.org/10.1016/j.jcv.2020.104380

Ejemplares similares

Treating Non-fentanyl-derived Synthetic Opioid Overdose with a Traditional Opioid Reversal Agent
por: Acuna, Valerie S, et al.
Publicado: (2020)

Tocilizumab as treatment for COVID-19: A systematic review and meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2021)

Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis
por: Wei, Qiu, et al.
Publicado: (2021)

Systematic review of the clinical consequences of butyrfentanyl and corresponding analogues
por: LE, Alexander Dinh, et al.
Publicado: (2019)

Tocilizumab for severe COVID-19: a systematic review and meta-analysis
por: Lan, Shao-Huan, et al.
Publicado: (2020)

Tocilizumab and COVID-19
por: Chaudhry, Dhruva, et al.
Publicado: (2020)

Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis
por: Piscoya, Alejandro, et al.
Publicado: (2022)

Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review
por: Cortegiani, A., et al.
Publicado: (2021)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Effectiveness of tocilizumab in the treatment of hospitalized adults COVID-19: A systematic review and meta-analysis
por: Zhang, Jing, et al.
Publicado: (2022)

Tocilizumab is recommended for the treatment of severe COVID-19
por: Zhou, Yonggang, et al.
Publicado: (2020)

Tocilizumab for treatment of mechanically ventilated patients with COVID-19
por: Somers, Emily C, et al.
Publicado: (2020)

Gamer's Thrombosis: A Review of Published Reports
por: Rambaran, Kerry Anne, et al.
Publicado: (2020)

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
por: Mikulska, Malgorzata, et al.
Publicado: (2020)

Tocilizumab, an Exploratory Treatment for Severe COVID-19 Patients
por: Wang, Yong, et al.
Publicado: (2022)

Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19
por: Somers, Emily C, et al.
Publicado: (2020)

Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19)
por: Chen, Chong-xiang, et al.
Publicado: (2021)

Use of Tocilizumab in COVID-19: A Systematic Review and Meta-Analysis of Current Evidence
por: Kotak, Sohny, et al.
Publicado: (2020)

Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors’ reply
por: Cortegiani, A., et al.
Publicado: (2021)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Time for tocilizumab in COVID-19?
por: Butler, Ethan, et al.
Publicado: (2021)

Association between tocilizumab treatment and clinical outcomes of COVID-19 patients: a systematic review and meta-analysis
por: Peng, Jingwen, et al.
Publicado: (2022)

Effective treatment of severe COVID-19 patients with tocilizumab
por: Xu, Xiaoling, et al.
Publicado: (2020)

563. Tocilizumab in the Treatment of Critical COVID-19 Pneumonia
por: Fisher, Matthew, et al.
Publicado: (2020)

The Treatment of COVID-19 Purgatory Syndrome With Tocilizumab and Steroids
por: Selvaraj, Vijairam, et al.
Publicado: (2022)

553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
por: Leonard, Michael, et al.
Publicado: (2020)

Tocilizumab and Systemic Corticosteroids in the Management of Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Alkofide, Hadeel, et al.
Publicado: (2021)

Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19
por: Hassoun, Ali, et al.
Publicado: (2020)

Successful treatment of a critical COVID-19 patient with tocilizumab
por: Tsao, Shih-Ming, et al.
Publicado: (2021)

Putting Out the Fire: The Relationship of Pharmacogenetics and Proton Pump Inhibitors for the Treatment of Gastroesophageal Reflux Disease
por: Zheng, Connor L, et al.
Publicado: (2018)

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
por: Langer-Gould, Annette, et al.
Publicado: (2020)

The Relationship of UGT2B15 Pharmacogenetics and Lorazepam for Anxiety
por: Ching, Nathan R, et al.
Publicado: (2018)

Thromboinflammation response to tocilizumab in COVID‐19
por: Gergi, Mansour, et al.
Publicado: (2020)

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
por: Tleyjeh, Imad M., et al.
Publicado: (2021)

Optimal use of tocilizumab for severe and critical COVID-19: a systematic review and meta-analysis
por: Nugroho, Cahyo Wibisono, et al.
Publicado: (2021)

Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis
por: Luo, Lili, et al.
Publicado: (2022)

Effectiveness of tocilizumab in non-intubated cases with COVID-19: a systematic review and meta-analysis
por: Keske, Şiran, et al.
Publicado: (2023)

Efficacy of tocilizumab in COVID-19: A review of the current evidence
por: Alam, Walid, et al.
Publicado: (2021)

An Unnecessary Pain: Using Pharmacogenetics for Statin-related Skeletal Muscle Toxicity
por: Alzghari, Saeed K
Publicado: (2018)

Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis
por: Conti, Valeria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ubb245bu36vukqg3rpl3v8et6c